Hyloris Pharmaceuticals SA 2022 AR2
The report outlines Hyloris' strategic and financial progress in 2022, including the expansion of its product pipeline to 14 product candidates, 2 marketed products, and 3 high-barrier generics. Key highlights include the relocation of its Belgian headquarters to the sustainable Legiapark life sciences hub and the release of its initial 2030 ESG Roadmap aligned with the UN Sustainable Development Goals. Financially, the company maintained a strong position with ’43 million in cash and ’3 million in revenues, driven by growing royalty income from Sotalol IV and Maxigesic_x0001_ IV. Hyloris also expanded its team to 37 employees representing 11 nationalities, while committing to future diversity targets such as achieving at least one-third female representation on its board by 2026.
Company: Hyloris Pharmaceuticals SA
Sector: Manufacturing
Country: Belgium
Year: 2022
Type: AR2
Pages: 71
Back to company
Hyloris Pharmaceuticals SA
Annual Report
The report outlines Hyloris' strategic and financial progress in 2022, including the expansion of its product pipeline to 14 product candidates, 2 marketed products, and 3 high-barrier generics. Key highlights include the relocation of its Belgian headquarters to the sustainable Legiapark life sciences hub and the release of its initial 2030 ESG Roadmap aligned with the UN Sustainable Development Goals. Financially, the company maintained a strong position with ’43 million in cash and ’3 million in revenues, driven by growing royalty income from Sotalol IV and Maxigesic_x0001_ IV. Hyloris also expanded its team to 37 employees representing 11 nationalities, while committing to future diversity targets such as achieving at least one-third female representation on its board by 2026.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2022
Reporting Period
Jan 1, 2022 - Dec 31, 2022
Fiscal Year
2022
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
Materiality Assessment
Assurance
Assurance Provider
Assurance Standard
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Women on Board
Women in Management
Employees